Molecular Microbiology (2010) 76(6), 1461â€“1482 äŠ?                                                              doi:10.1111/j.1365-2958.2010.07151.x
                                                                                                               published online 15 April 2010


 essential neutral sphingomyelinase involved trafï¬?cking variant surface glycoprotein bloodstream form Trypanosoma brucei                                                  mmi_7151 1461..1482




Simon  Young Terry K. Smith*                                    Introduction
Biomolecular Science, North Haugh, University,
St. Andrews, Fife Scotland KY16 9ST, UK.                              medically important protozoan kinetoplastid Trypano-
                                                                      soma brucei, cause African sleeping sickness,                                                                       complex life cycle alternates insect
Summary                                                               vector mammalian host (Matthews, 2005). Despite
Sphingomyelin main sphingolipid Trypano-                    phospholipid content life cycle
soma brucei, causative agent African sleeping                  stages remarkably similar (Patnaik et al., 1993; Rich-
sickness. vitro vivo characterization                mond et al., 2010). Phosphatidylcholine (PC) sphin-
T. brucei neutral sphingomyelinase demonstrates                       gomyelin (SM) abundant phospholipid directly involved sphingomyelin catabo-                 species eukaryotic cells accounts half lism. Gene knockout studies bloodstream                        total phospholipids T. brucei membranes (Patnaik
form parasite indicate neutral sphin-                 et al., 1993).
gomyelinase essential growth survival,                        Sphingolipids, common SM, highlighting novo biosynthesis                    essential structural components eukaryotic mem-
ceramide unable compensate loss                      branes, function diverse cellular processes (Cowart
sphingomyelin catabolism. phenotype                        et al., 2006; Lahiri Futerman, 2007). abun-
conditional knockout given new insights                      dant outer leaflet plasma membrane highly active endocytic exocytic pathways                  cells lysosomal membranes bloodstream form T. brucei.  forma-                  endoplasmic reticulum (ER) Golgi, tion ceramide endoplasmic reticulum                         play important role controlling membrane fluidity
affects post-Golgi sorting rate deposition                  (Koynova Caffery, 1995; van Meer et al., 2008).
newly synthesized GPI-anchored variant surface gly-                      Eukaryotic SM synthase activity observed coprotein cell surface. directly influ-                   plasma membrane, primarily localized ences corresponding rate endocytosis,                  Golgi, transfers cholineâ€“phosphate head-
recycling endosomes, pre-existing cell surface                     group PC ceramide. Ceramide formed
variant surface glycoprotein. trypanosomes use                    novo biosynthesis, commences coupled endocytic exocytic mechanism                      condensation serine palmitoyl-CoA, maintain cell density crucial variant                      hydrolysis (degradation) complex sphingolipids 
surface glycoprotein protective coat. TbnSMase                     mally sphingomyelinases (SMases) (Futerman genetically validated drug target                      Riezman, 2005). African trypanosomes, suggests                               diversity sphingolipid synthesis developing interfering endocytic transport                      area anti-fungals yeast synthesize significant
variant surface glycoprotein highly desirable                    amounts inositol phosphorylceramide (IPC), strategy drug development African                         transfer inositol-1-phosphate headgroup phos-
trypanosomasis.                                                       phatidylinositol (PI) ceramide, contrast                                                                       mammals, synthesize SM (Dickson et al.,
                                                                      2006). Similarly various sphingolipid species Accepted 22 March, 2010.  correspondence. E-mail tks1@st-
andrews.ac.uk; Tel. (+44) 1334 463412; Fax (+44) 1334 462593.     biosynthesis kinetoplastid parasites drawn
nucleotide sequence(s) reported paper submitted   attention potential novel chemotherapeutic EBI Data Bank accession number(s) FM992873.                  targets (Suzuki et al., 2008). Trypanosoma cruzi use article permitted accordance Terms Conditions set http://www3.interscience.wiley.com/         Leishmania synthesize significant amounts IPC
authorresources/onlineopen.html                                       (Kaneshiro et al., 1986; Bertello et al., 1995; Uhrig et al.,
Â© 2010 Blackwell Publishing  1462 S.  Young T. K. Smith äŠ?

1996; Zhang et al., 2007) orthologues yeast           GPI-dependent trafficking trypanosomes unclear
AUR1 inositol phosphoceramide synthase (Denny et al.,            (Denny Smith, 2004).
2006). viability Leishmania major promastigote             Seminal work Bangsâ€™ group resulted null serine palmitoyltransferase, enzyme     hypothesis post-Golgi sorting soluble GPI- sphingoid base pathway, suggests Leishmania          anchored cargo influenced endocytic rate require sphingolipids (Zhang et al., 2003).       particular life cycle stage T. brucei (Tazeh et al., 2009). subsequently discovered use sphingosine          stage-specific variation mirrored depen-
lyase generate ethanolamine (Zhang et al., 2007).             dency clathrin endocytosis bloodstream stage
   Procyclic T. brucei contain SM IPC (GÃ¼ther           (Allen et al., 2003), enlarged flagellar pocket,
et al., 2006; Fridberg et al., 2008), bloodstream          known â€˜Big-Eyeâ€™ phenotype observed mem-
stage parasites contain IPC synthesizing SM          brane vesicles continue delivered flagellar
minor amounts ethanolamine phosphorylceramide                 pocket, internalized endocytic
(EPC) (Bagnat et al., 2000; Sutterwala et al., 2008).            pathway flagellar pocket; site endocy-
Recently, discovered mammalian stumpy           tosis exocytosis parasites (reviewed form T. brucei upregulate mitochondrial SM synthase            Overath Engstler, 2004).
(SLS1, Tb09.211.1030) (Kabani et al., 2009), responsible            Intracellular degradation sphingolipids achieved making IPC (Mina et al., 2009), paralleled       SMases [EC. 3.1.4.12], catalyses hydrolysis formation IPC identified electrospray mass           form ceramide corresponding headgroup e.
spectrometry (ES-MS) (Kabani et al., 2009).                      phosphorylcholine case SM.
    observations clearly indicate sph-          Various SMases described, differ ingolipid synthesis African trypanosomes develop-          subcellular localization, tissue specificity mentally regulated. RNAi silencing TbSLS locus            normally activated growth factors, cytokines, chemo-
 tandem genes) leads growth arrest, suggesting           therapeutic agents, irradiation, nutrient removal synthesis sphingolipids essential          related stresses (Tomiuk et al., 1998; Yabu et al., 2008).
trypanosomes (Sutterwala et al., 2008).                          thought regulate intracel-
   yeast, sorting glycosylphosphatidylinositol         lular ceramide concentration corresponding
(GPI)-anchored proteins influenced sphingolipid-           stress-induced associated responses. ergosterol-rich lipid rafts (Zanolari et al., 2000),        date, main types SMases; acidic yeast dependent novo synthesis cera-           Zn2+-dependent (cytosolic/secreted) independent
mide (Sutterlin et al., 1997). ceramide synthesized      (lysosomal), neutral Mg2+-dependent (membrane) ER transferred Golgi, process     independent (cytosolic) lastly secreted alkaline independent ATP vesicular trafficking (Funato          SMase (reviewed Goni Alonso, 2002). Reizman, 2001). resulting IPC synthesized            growing body evidence suggests
Golgi (Levine et al., 2000) essential stable mem-         Mg2+-dependent neutral SMases (nSMases) major
brane association GPI-anchored proteins subse-            source stress-induced ceramide production (Yabu
quently correct sorting trafficking plasma      et al., 2008). Ceramide associated metabolites, membrane (Watanabe et al., 2002).                                sphingosine-1-phosphate, known function    Sphingolipid/cholesterol-rich membrane lipid rafts         second messengers, causing various biological activities
polarized mammalian epithelial cells impli-       mammalian cells, including activation protein-
cated associated GPI anchors, strongly          kinases protein-phosphatases 2A (Huwiler et al.,
influences sorting proteins leaving Golgi         2000). Increased levels ceramides exert anti-
reviews Muniz Reizman, 2000; Chatterjee               proliferation effects, induce apotosis play major roles
Mayor, 2001).                                                    mitogenesis endocytosis.
   abundant GPI-anchored variant surface glycopro-              Neutral SMases cloned Bacillus cereus
tein (VSG) strongly influences trafficking       (Yamada et al., 1988), allowed identification
secretory endocytic pathways bloodstream-stage            nSMases bacteria including Listeria
African trypanosomes (Engstler et al., 2004; Schwartz            ivanovii (Gonzalez-Zorn et al., 1999). homology Bangs, 2006). Inhibition initial step sph-     searches yeast homologues (Sawai et al., 1999) ingolipid biosynthesis, essential viability,     subsequently mammalian homologues identified
surprisingly detrimental effect VSG          (Tomiuk et al., 1998; Hofmann et al., 2000). Despite trafficking cell surface (Sutterwala et al., 2007),       extensive literature nSMase activity compara-
despite reports presence VSG detergent-             tively recently mammalian nSMases resistant membranes (Nolan et al., 2000; Denny et al.,           cloned characterized. Neutral SMases ubiqui-
2001).  extent lipid rafts influence     tously expressed mammalian cells, 
                                                         Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                          Neutral sphingomyelinase Trypanosoma brucei 1463

predominately membrane-bound outer leaflet               organisms, significant regions sequence, plasma membrane (Tomiuk et al., 1998),              different kinetoplastid nSMase SM located.                                              homologues (identified  nSMases
   Plasmodium contains bacterial nSMase homo-               including human protein. Outside kinetoplasts
logue, capable cleaving SM lyso-PC            closest homologue surprisingly honey-bee
(Hanada et al., 2002). Intriguingly, compound scy-             (Apis mellifera).
phostatin inhibits plasmodium enzyme activity, preventing maturation trophozoite schizont                                                                    Overexpression TbnSMase E. coli
low mM concentrations (Hanada et al., 2000).
   yeast nSMase homologue Isc1 shown               enable biochemical characterization, TbnSMase associated ER, early growth,           recombinantly expressed E. coli using pGEX-6P-1
late logarithmic growth outer leaflet    vector. N-terminal GST fusion protein  length,
mitochondria regulate sphingolipid               membrane bound) expressed E. coli C43 (DE3)
metabolism (Vaena Avalos et al., 1998; Kitagaki et al.,         cells, bacterial host allows synthesis poten-
2007). Isc1 protein inositol sphingolipid phospho-         tially toxic membrane proteins (Miroux Walker,
lipase C activity, e. capable cleaving IPC generate        1996). apparent molecular weight GSTâ€“
ceramide, required normal mito-              TbnSMase fusion protein ~81 kDa Western blot
chondrial function (Sawai et al., 2000). recent            analysis (Fig. 1A, lane 2), smaller predicted
studies elaborated  clearly showing           size 91 kDa (including GST tag). significant pro- knockout Isc1 essential diauxic shift, e.     portion protein expected plays crucial role reprogramming mitochon-          membrane fraction (Fig. 1A, lane 3). membranes
drial gene expression transition anaerobic         washed phosphate-buffered saline (PBS) aerobic metabolism, coupled change carbon             suspended 100 mM Tris (pH 7.4), 10 mM MgCl2 buffer
source (Kitagaki et al., 2009).                                    containing 20  glycerol, aliquots stored    study, begin investigate catabolism        -80Â°C loss activity. Total protein content sphingolipids T. brucei.                                        calculated 50.8 mg ml-1 membrane prepara-
   recombinant expression charac-             tion. Enzyme activity assessed incubation terization T. brucei nSMase. report         GSTâ€“TbnSMase containing membranes (127 mg protein) creation T. brucei conditional null mutant,         25 nCi/50.5 pmol [3H-choline-methyl] SM demonstrates nSMase activity essential         30 nCi/50.5 pmol [3H-choline-methyl] PC, mixed
bloodstream form parasite, causing VSG trafficking          micelles 0.1  Triton-X 100. Reactions incu- impaired.                                                    bated 37Â°C 120 min 100 mM Bis-Tris propane
                                                                   (pH 7.5), 5 mM MgCl2, 1  glycerol presence                                                                    absence 5 mM EDTA. Chloroform/methanol/water
Results                                                            phase separation used distinguish radiola-
                                                                   belled lipid substrates aqueous radiolabelled
Cloning sequencing T. brucei nSMase
                                                                   products, subjected scintillation counting nSMase homologue putatively identified T.            layer chromatography. assay showed b. brucei (strain 927) genome database (Sanger Insti-              membranes containing GSTâ€“TbnSMase cata-
tute) interrogating Saccharomyces cerevisiae           lytically active (Fig. 1B, compare lanes 1 2) nSMase (Isc1). open reading frame (ORF)                       divalent cation-dependent (Fig. 1B, compare lanes
(Tb927.5.3710) PCR-amplified T. b. brucei                 2 3). activity PC apparent (Fig. 1B,
strain 427, subcloned sequenced. sequence                  lanes 6â€“8), SMase activity observed submitted EMBL-EBI, Accession                       equivalent E. coli membranes containing
FM992873. alignment predicted translated                 GSTâ€“TbnSMase (Fig. 1B, lanes 4 5). optimum
sequence nSMases organisms shown                pH GSTâ€“TbnSMase activity pH 8, Fig. S1A unrooted phylogenetic tree                   little activity pH 5.5 (Fig. 1C), representative Fig. S1B. predicted 65 kDa T. brucei nSMase                    nSMase.
(TbnSMase) putative transmembrane domains                      Sphingomyelinase activity similarly detected
(Fig. S1A, underlined) C-terminus,           use multi plate, fluorescence-
present eukaryotic nSMases, contains               based, coupled assay (Invitrogen), product
conserved residues critical catalytic activity Mg2+        SMase activity, cholineâ€“phosphate, hydrolysed binding (Fig. S1A, asterisks). TbnSMase shows             alkaline phosphatase, released choline oxi-
considerable similarity nSMases variety               dized betaine H2O2 (Fig. 2A). Production H2O2

Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1464 S.  Young T. K. Smith äŠ?

                                                                                    Fig. 1. Expression, purification activity
                                                                                    recombinant TbnSMase.
                                                                                     TbnSMase cloned expressed
                                                                                    N-terminal GST fusion protein C43
                                                                                    E. coli. Protein samples cell disruption
                                                                                    separated 10  SDS-PAGE gel,
                                                                                    transferred membrane detected                                                                                     anti-GST antibody. Lane 1, soluble protein
                                                                                    (supernatant 100 000 g); lane 2,
                                                                                    membrane fraction (pellet 100 000 g);
                                                                                    lane 3, insoluble fraction (pellet                                                                                     45 000 g).
                                                                                    B. substrate [3H]-sphingomyelin (SM)                                                                                     product [3H]-cholineâ€“phosphate                                                                                     TbnSMase assay separated phase
                                                                                    partitioning (organic aqueous
                                                                                    respectively), analysed HPTLC                                                                                     detected autoradiography described                                                                                     Experimental procedures. Lane 1, negative
                                                                                    control, [3H]-SM membranes; lane 2,
                                                                                    [3H]-SM TbnSMase; lane 3, [3H]-SM                                                                                     TbnSMase presence EDTA (5 mM); lane
                                                                                    4, negative control, [3H]-SM non
                                                                                    expressing TbnSMase membranes; lane 5,
                                                                                    [3H]-SM non-expressing TbnSMase
                                                                                    membranes EDTA (5 mM).; lane 6,
                                                                                    [3H]-PC membranes; lane 7, [3H]-PC
                                                                                    TbnSMase; lane 8, [3H]-PC                                                                                     TbnSMase presence EDTA (5 mM).
                                                                                    Percentages substrate turnover shown,
                                                                                    determined densitometry (ImageJ
                                                                                    software).
                                                                                    C. TbnSMase activity determined                                                                                     end-point radioactive assay function                                                                                     pH, using MES buffer (filled triangles)                                                                                     Bis-Tris Propane (filled squares) described
                                                                                    Experimental procedures.



 presence horseradish peroxidase drives             bovine nSMase (detergent extracted bovine brain
conversion Amplex Red reagent red-                 membranes) apparent Km ~40 mM spe-
fluorescent resorufin, detectable using fluorescence           cific activity 371 nmol h-1 mg-1 (Bernardo et al., 2000);
microplate reader (Molecular Devices Gemini XPS).            (iii) human nSMase1  nSMase expressed
TbnSMase activity showed saturation kinetics                HEK293 cell lysates) Km 26.2 â«¾ 10.5 mM observed, apparent Km 45.7 â«¾ 6.5 mM               specific activity 126.8 â«¾ 17.4 nmol h-1 mg-1) (Sawai
Vmax 424.0 â«¾ 32.6 nmol h-1 mg-1 membrane protein              et al., 1999).
(Fig. 2B).                                                          Sphingomyelinase activity, slightly reduced rate,
   homologous divalent cation-dependent nSMases            detected using equivalent amounts E. coli
assayed similar manner similar kinetic proper-         membranes expressing N-terminal tagged
ties including following:   S. cerevisiae ISC1        version TbnSMase protein (Fig. S2), expressed S. cerevisiae JK9-3da cell lysates) Km       activity detected PC (Fig. S2, lane 3). 34.8 mM Vmax 9200 nmol h-1 mg-1 (Sawai et al.,       fluorescence-based coupled assay amenable 2000); (ii) Plasmodium falciparum nSMase (GST                high-throughput screening inhibitors recombi-
fusion expressed E. coli membranes) apparent          nant TbnSMase. allowed determination IC50
Km ~90 mM specific activity 5.69 â«¾                   values various compounds including known nSMase
0.29 nmol h-1 mg-1 (Hanada et al., 2002). mamma-           inhibitors dihydroimidazolo-amide GW4869
lian homologues kinetically characterized:        (Luberto et al., 2002) Manumycin (Fig. 2C) (Arenz
  rat nSMase (GST fusion partially purified E. coli )     et al., 2001), gave IC50 values 14.4 â«¾ 2.3 mM apparent Km 3.85 â«¾ 0.73 mM Vmax              24.6 â«¾ 4.6 mM respectively. Manumycin 239.1 â«¾ 33.2 nmol h-1 mg-1 (Mizutani et al., 2000); (ii)         ED50 10.0 â«¾ 6.5 mM;  noted

                                                         Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                                    Neutral sphingomyelinase Trypanosoma brucei 1465




Fig. 2. Activity recombinant TbnSMase.  Reaction catalysed TbnSMase coupled coupled Amplex red assay. AP, alkaline phosphatase; ChOx, choline oxidase;
Cho-P, cholineâ€“phosphate; HRP, horseradish peroxidase.
B. Determination TbnSMase Michaelis-Menten constants SM (inserts Lineweaverâ€“Burk plot).
C. Structure manumycin  commercially available nSMase inhibitor.
D. Enzyme activity TbnSMase washed bloodstream T. brucei membranes (lanes 1â€“3) E. coli membranes expressing
GSTâ€“TbnSMase (lanes 4â€“6), pre-incubation (lanes 1 4) miltefosine (lanes 2 5) edelfosine (lanes 3 6) presence SM substrate described Experimental procedures. Insert shows structure edelfosine.

 previously shown trypanocidal,                     nSMase activity T. brucei membranes (Fig. 2D, suggestion farnesyl transferase                    lanes 1â€“3) recombinant GSTâ€“TbnSMase activity
inhibitor (Ali et al., 1999), light findings            (Fig. 2D, lanes 4â€“6). Edelfosine potent Manumycin multiple trypanocidal                         miltefosine, IC50 21.0 â«¾ 3.2 mM
targets. lyso-PC analogues miltefosine edelfos-                   recombinant GSTâ€“TbnSMase (Fig. 2D,
ine (structure insert Fig. 2D) inhibitors                 lane 6).

Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1466 S.  Young T. K. Smith äŠ?

                                                                         TbnSMase essential gene bloodstream form
                                                                         T. brucei

                                                                         Southern blot analysis T. brucei genomic DNA
                                                                         showed TbnSMase present single copy gene
                                                                         haploid genome (data shown), RT-PCR
                                                                         analysis clearly shows TbnSMase expressed
                                                                         bloodstream procyclic forms parasite
                                                                         (Fig. S4), making amenable genetic validation
                                                                         drug target. allele TbnSMase replaced
                                                                         knockout cassette containing puromycin drug
                                                                         resistance gene, homologous recombination                                                                          selection puromycin, creating DTbnSMase::PAC
                                                                         cell line (Fig. 4A, Lane 1). Attempts create null
                                                                         mutant homologous replacement second allele
                                                                         hygromycin resistance gene unsuccessful.
                                                                          â€˜wild-typeâ€™ cell line used consti-
                                                                         tutively expresses T7 RNA polymerase tet-
                                                                         racycline repressor protein, tetracycline-inducible (Ti)
                                                                         HA-tagged ectopic copy TbnSMase inte-
                                                                         grated rDNA locus (Wirtz et al., 1999) modi-
                                                                         fied version pLew100 vector encoding                                                                          blasticidin drug resistance protein (previously 
                                                                         structed Smith lab) forming TbnSMase-HA Ti
                                                                         DTbnSMase::PAC cell line (Fig. 4A, Lane 2). second
                                                                         allele replaced hygromycin resistance
                                                                         gene presence tetracycline. TbnSMase-
Fig. 3. Localization TbnSMase-HA Ti bloodstream form               HA Ti DTbnSMase::PAC/DTbnSMase::HYG clone T. brucei.                                                               obtained genotype confirmed Southern blot  Fixed TbnSMase-HA Ti cells incubated rat anti-HA
                                                                         analysis (Fig. 4A, Lane 3). establish essentiality
antibody, rabbit anti-rat FITC conjugated antibody DNA
stained DAPI.                                                       TbnSMase bloodstream T. brucei, growth B. Anti-HA Western analysis fractions differential               TbnSMase-HA Ti DTbnSMase::PAC/ DTbnSMase::HYG
centrifugation, 14 500 g pellet (1), 140 000 g pellet (2)                                                                          conditional knockout (cKO) cell line monitored supernatant 140 000 g pellet (3) TbnSMase-HA Ti cells,
prepared described Experimental procedures.                    absence presence tetracycline certified
                                                                         tetracycline-free HMI-9. presence tetracycline
                                                                         cKO cell line showed normal growth rates nSMase located endoplasmic reticulum                                                                          compared wild-type cells (Fig. 4B).  bloodstream form T. brucei
                                                                         absence tetracycline, cells grew normally ~24â€“ cellular location TbnSMase investigated using                 28 h ceasing division steadily declined cell tetracycline-inducible overexpression vector pLew82,                 numbers limits detection light micros-
containing length TbnSMase C-terminal                      copy day 5. day 10  live cells HA-tag. construct introduced bloodstream                   visualized having wild-type morphologies subse-
form T. brucei cells, generating cell line TbnSMase-                 quently resumed normal growth kinetics. RT-PCR analy-
HA Ti integration confirmed PCR using specific                sis showed transcript level ectopic
vector primers (data shown). Tetracycline-induced                    TbnSMase-HA Ti similar endogenous
TbnSMase-HA Ti cells fixed, adhered poly-lysine                  copy seen wild-type cells (Fig. 4C, compare lanes1
slides permeablized. TbnSMase-HA Ti protein                      2). absence tetracycline 24 h tran- detected immunofluorescence perinuclear                      script TbnSMase-HA Ti undetectable (Fig. 4C,
staining reticular cytoplasmic signal (Fig. 3A                 lane 3), revertant cells, transcript Fig. S3), suggesting TbnSMase localized                   TbnSMase-HA Ti clearly shown (Fig. 4C, lane 4), ER. confirmed subcellular fractionation                  suggesting revertant cells overcome tet-
studies, membrane bound TbnSMase-HA                            racycline control, phenomena described
protein detected microsomal fraction                  essential genes T. brucei (Chang et al., cytosolic fraction (Fig. 3B).                                        2002; Roper et al., 2002; Martin Smith, 2006a).

                                                                 Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                          Neutral sphingomyelinase Trypanosoma brucei 1467

                                                                                     Fig. 4. TbnSMase essential                                                                                      survival bloodstream form Trypanosoma
                                                                                     brucei culture.
                                                                                      Confirmation genotype T. brucei
                                                                                     TbnSMase conditional double knockout cell
                                                                                     line. Southern blot analysis Pst1-digested
                                                                                     genomic DNA (3 mg); TbnSMase ORF
                                                                                     probe shows allelic TbnSmase 4 kb                                                                                      ectopic copy â€“ TbnSMase-HATi ~2 kb;
                                                                                     parental cells (lane 1);
                                                                                     DnSMase:::PAC/TbnSMase-HATi (lane 2);
                                                                                     DnSMase:::PAC
                                                                                     DnSMase:::HYG/TbnSMase-HATi (lane 3).
                                                                                     B. Growth curves T. brucei parental cells (1
                                                                                     â€“ filled squares) TbnSmase conditional
                                                                                     knockout cells grown presence (2 â€“
                                                                                     circles) absence (3 â€“ filled triangles)
                                                                                     tetracycline.
                                                                                     C. RT-PCR amplification TbnSMase RNA
                                                                                     transcripts total RNA extracted                                                                                      wild-type cells (lane 1) TbnSMase
                                                                                     conditional null mutants grown                                                                                      presence (lane 2) absence tetracycline
                                                                                     1 10 days (lanes 3 4
                                                                                     respectively). upper panel shows RT-PCR
                                                                                     products using primers specific                                                                                      TbnSMase; lower panel shows loading
                                                                                     control using (TbINO1) primers.




Lipidomic analysis nSMase conditional knockout              parent species collision-induced daughter ion char-
                                                                   acteristic PC SM phospholipids (parents biochemical phenotype TbnSMase condi-                   184 m  observed wild-type cKO cells
tional knockout cells investigated using mass            cultured absence tetracycline 42 h (TbnS-
spectrometry examine differences phospholipid                Mase cKO (42hâ€“tet)) (Fig. S5). minor
species wild-type nSMase conditional               changes detected corresponding negative ion
knockout trypanosomes. Based growth curve                   survey scans (Fig. S6A). Parent ion neutral loss
(Fig. 4B), 42 h tetracycline chosen             scanning individual phospholipid classes acquired
optimum time point characterize TbnSMase cKO                PI, phosphatidylethanolamine (PE), phosphati-
phenotype, cells viable metaboli-            dylserine (PS) (Fig. S6Bâ€“D). difference cally active. hours later (48hâ€“tet) case,      note compared wild-type bloodstream form 42 h deemed extreme point               phospholipid spectra unexpected presence investigate advanced phenotype studying             inositolphosphorylceramide (IPC) (34:1, 778m 
dying cells.                                                       (Fig. S6B, arrow).
   Initially, ES-MS used examine phospholipid              Consequently, hypothesized potential
content cell extracts TbnSMase-depleted              differences phospholipid profiles par-
cells, focussing initially positive ion mode detec-     ticular organelle ER.  lipids tion PC SM.  differences             extracted microsomal fraction (100,000g pellet,

Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1468 S.  Young T. K. Smith äŠ?

                                                                                     Fig. 5. Mass spectrometric analyses                                                                                      phospholipids. Choline-containing
                                                                                     phospholipids extracted P100
                                                                                     fraction described Experimental
                                                                                     procedures analysed ESI-MS/MS                                                                                      positive ion mode using parent-ion scanning
                                                                                     collision induced fragment                                                                                      phosphorylcholine 184 m   parental
                                                                                     cells. (B) TbnSMase cKO cells grown                                                                                      absence tetracycline 42 h. ESI-MS
                                                                                     negative ion survey scan spectra P100 lipid
                                                                                     extracts T. brucei bloodstream form cells.
                                                                                     (C) Parental cells. (D) TbnSMase cKO cells
                                                                                     grown absence tetracycline 42 h.
                                                                                     Asterisks highlight ions, altered
                                                                                     significantly intensity, described                                                                                      text.




P100), representing internal organelle membranes,            phosphatidylglycerol (PG) (diacyl, C36:3, mixture wild-type TbnSMase cKO (42hâ€“tet) trypano-                C18:1, C18:2 C18:0, C18:3). corresponding
somes analysed ES-MS ES-MS-MS.                    negative ion survey scan TbnSMase cKO (42hâ€“
collision-induced daughter ion scanning cholineâ€“              tet) P100 fraction (Fig. 5D), showed PG (diacyl,
phosphate phospholipids (parents 184 m , e. PC             C36:3) species major species;  SM (Fig. 5A B), differences observed.                significant increase species 641 m included significant decrease PC species           669 m (Fig. 5D, marked asterick), identified 771 m (alkylacyl 36:2), minor decreases        ES-MS/MS daughter ion fragmentation (Fig. S7B), PC species 807 m (diacyl C38:5) 835 m (diacyl          diacylglycerol (DAG) species C38:5 (C16:0, C22:5) C40:5) (Fig. 5A B, species highlighted asterisks).       C40:5 (C18:0, C22:5) respectively. cell decrease contrast significant increase     extracts, presence IPC (34:1, 778m  SM species 703 m (C16:0) minor increases          observed TbnSMase cKO (42hâ€“tet) P100 fraction SM species 677 m (C14:0) 731 m (C18:0).            inositol-phosphate containing phospholipids (parents
Fully characterization cholineâ€“phosphate contain-          241 m  (Fig. S7C). IPC normally present ing phospholipids T. brucei shown Table S1 (Rich-        bloodstream form T. brucei, procyclic mond et al., 2010).                                               stumpy form parasites (GÃ¼ler et al., 2008; Kabani et al.,
  contrast, negative ion survey scan P100           2009).
subcellular membrane fraction wild-type cells (Fig. 5C)          Taken  set data clearly shows showed major species 771 m  identified           increase SM species organelle level ES-MS/MS daughter ion fragmentation (Fig. S7A)                 lack nSMase activity. corresponding decrease 
                                                          Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                           Neutral sphingomyelinase Trypanosoma brucei 1469

PC explainable lack cholineâ€“phosphate               phase-light structures (Fig. 6C, D N), larger
product SM hydrolysis TbnSMase ER,             flagellar pocket confirmed original, smaller
reducing flux Kennedy pathway                daughter flagellar pocket exocytically active prior novo PC biosynthesis. Alternatively, likely concur-        cytokinesis (Allen et al., 2003). Associated â€˜Big-
rently, SM synthesized expense deplet-          Eyeâ€™ phenotype noticeable increase pre-
ing pool PC SM synthases.                            cytokinesis 2K2N cells. lack proper cell-division                                                                    TbnSMase cKO (-tet) confirmed FACS analy-
                                                                   sis, showed significant increase proportion
Loss nSMase activity leads                                                                    G2/M, corresponding decrease G0/G1 cells
â€˜Big-Eyeâ€™-like phenotype
                                                                   (Fig. 6P), implying cell cycle arrest G2/M. TbnSMase cKO cell line grown absence                    ensure enlargement flagellar pocket tetracycline exhibited phase light structure poste-       cell line similar previously described â€˜Big-Eyeâ€™
rior end, significantly increases volume time.       defect endocytosis phenotype, previously  enlarged structure eventually major               characterized proteins sorted endosomal
proportion cell volume trypanosomes                 network investigated. rounded time (Fig. 6Bâ€“D) compared wild-type cells (Fig. 6A). Concurrently, proportion                                                                    Does loss nSMase affect protein trafficking? abnormal cells increased time 42 h, ~25  nSMase cKO cells exhibit morphology,            diagnostic marker membrane protein trafficking increasing 50  cells 72 h, compared         bloodstream form T. brucei, processing p67 <1  wild-type cells. morphology similar          TbnSMase cKO cells examined. docu-
â€˜Big-Eyeâ€™ phenotype described previously RNA              mented terminal endosomal marker p67, type interference (RNAi) clathrin heavy chain T. brucei       membrane protein, undergoes complex processing bloodstream forms (Allen et al., 2003). Allen col-             bloodstream form trypanosomes (Brickman Balber,
leagues used immunogold VSG electron microscopy               1994). synthesis ER-associated 100 kDa
confirm phase light structure flagellar           glycoprotein (gp100), p67 N-glycosylated pocket, massively enlarged small flask-shaped             150 kDa species (gp150) Golgi, trans-
structure usually seen wild-type cells.                         ported proteolytically cleavage lysosome,
   Electron microscopy TbnSMase cKO grown                   forming firstly gp75 subsequently gp28, gp32, gp42. permissive conditions showed highly                 Using method Alexander et al. (2002), process-
enlarged flagellar pocket (Fig. 6Hâ€“J), compared               ing monitored.  wild-type TbnSMase wild-type cells (Fig. 6Eâ€“F, EM micro-             cKO (42hâ€“tet) cells pulse labelled 1 h [35S]-
graphs Fig. S8).                                                methionine immunoprecipitation 0 2 h post
   â€˜Big-Eyeâ€™ enlargement flagellar pocket          pulse, using monoclonal p67 (mAb280 â€“ gift J. attributed defect membrane transport            Bangs). Analysis [35S]-methionine-labelled immuno- balance exocytosis endocytosis disturbed.           precipitates SDS-PAGE autoradiography revealed
   decrease fluid endocytosis TbnSMase cKO               proteolytic processing p67 gp75
(42hâ€“tet) cells (Fig. 6Lâ€“N), compared wild-type               intermediate end products gp32 gp42 cells (Fig. 6K), confirmed FITC-BSA uptake                unaffected lack TbnSMase (Fig. 8A, compare immunofluorescence. FITC-BSA signal                  lanes 1 2, 3 4, loading controls Fig. S9).
observed frequently endosomal network occa-                Similarly, trafficking lumenal proteins sionally flagellar pocket wild-type cells (Fig. 6K),     TbnSMase cKO cells investigated examining significantly frequently associated just      processing trypanopain, cathepsin L orthologue. flagellar pocket TbnSMase cKO (42hâ€“tet) cells;         wild-type bloodstream form trypanosomes, trypanopain fraction endocytosed 30 min (Fig. 6O, lanes             synthesized 53 kDa pro-protein rapidly
4â€“6), compared significant portion FITC-BSA          fully processed acidic environment endoso- endocytosed wild-type cells (Fig. 6O,                 mal network 44 kDa mature active enzyme
lanes1â€“3) (Fisherâ€™s exact test, P = 0.056, n = 40 fields).         (Caffrey et al., 2001), similarly observed Extreme morphological â€˜Big-Eyeâ€™ trypanosomes typically             using Western blot analysis trypanopain Ab
demonstrated specific FITC staining longer             gift J. Bangs) (Fig. 8B, lane 1).  TbnS-
camera exposures (Fig. 6H).                                        Mase cKO (42hâ€“tet) cells, proteolytic processing    clathrin RNAi â€˜Big-Eyeâ€™ trypanosomes,               trypanopain incomplete 2â€“5  immature
TbnSMase cKO (42hâ€“tet) cells seen                   53 kDa pro-enzyme detectable Western blot (Fig. 8B,
undergoing mitosis presented                lane 2).

Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1470 S.  Young T. K. Smith äŠ?

                                                                Fig. 6. Morphological phenotype                                                                 TbnSMase conditional knockout.
                                                                Aâ€“D. Merged DAPI-fluorescence-DIC images
                                                                wild-type  , TbnSMase cKO cells
                                                                grown absence tetracycline 42 h
                                                                (Bâ€“D).
                                                                Eâ€“J. Transmission electron micrographs taken
                                                                wild-type bloodstream T. brucei (Eâ€“G)                                                                 TbnSMase cKO cells grown absence                                                                 tetracycline 42 h (Hâ€“J). Insert   shows
                                                                close plasma membrane,
                                                                microtubles fussy VSG coat. FL,
                                                                flagellum; FP, flagellar pocket; K, kinetoplast;
                                                                M, mitochondria; G, glycosome; asterisk
                                                                (J) indicates enlarged concentric
                                                                membrane structure                                                                 endosomal network.
                                                                Kâ€“O. Wild-type (K) TbnSMase cKO cells
                                                                grown absence tetracycline 42 h
                                                                (Lâ€“N) incubated FITC-BSA                                                                 described Experimental procedures; images
                                                                merged FITC, DAPI-fluorescence                                                                 DIC. (O) Evaluation endocytic function
                                                                wild-type (1â€“3) nSMase cKO (Tet-42h)
                                                                (4â€“6) trypanosomes assessed                                                                 incidence FITC-BSA signal solely
                                                                endosomal region (1 4), dual
                                                                endosomal flagellar pocket staining (2
                                                                5) flagellar pocket staining (3
                                                                6).
                                                                P. FACS analysis TbnSMase cKO cells
                                                                grown absence tetracycline 0, 24
                                                                42 h. Cells fixed, stained                                                                 propidium iodide analysed flow
                                                                cytometry described Experimental
                                                                procedures.




                                     Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                          Neutral sphingomyelinase Trypanosoma brucei 1471

                                                                                     Fig. 7. Investigation endosomal
                                                                                     network. Wild-type cells   TbnSMase
                                                                                     cKO cells grown absence                                                                                      tetracycline 42 h (Bâ€“D) probed                                                                                      anti-trypanopain. Images TRITC,
                                                                                     DAPI-fluorescence DIC.




   Examination TbnSMase cKO cells (42hâ€“tet)              ~80 kDa glycoprotein species (Fig. S11), indicating subcellular localization trypanopain, typically           drastic defect processing.
colocalizes p67 lysosome (Caffrey et al., 2001),
shows endosomal staining pattern greatly
                                                                   Does loss nSMase affect VSG trafficking?
enlarged (Fig. 7Bâ€“D Fig. S10) compared corresponding wild-type staining pattern (Fig. 7A).             investigate effect,  exocytosis newly
addition, extension endosomal staining congru-           synthesized VSG reaching flagellar pocket, cells ent expansion late endosomal network           labelled [35S]-methionine 1 h, total
flagellar pocket. indicates endosomal                protein soluble VSG (sVSG) preparations (obtained
network malfunctioning, probably result lack         GPI-PLC cleavage cell surface VSG mild
flux endocytic pathways.                               hypotonic lysis) separated SDS-PAGE [35S]-
   malfunctioning endosomal network                labelled proteins detected autoradiography. Note:
account unusual  far know, novel              equal cell equivalents loaded gel, structures observed electron microscopy            â€˜Big-Eyeâ€™ 2K2N pre-cytokinesis phenotype, actual
sections TbnSMase cKO cells (42hâ€“tet) (Fig. 6I          total protein 1.4 times higher TbnS-
J Fig. S8F G) consisting concentric â€˜onion-likeâ€™        Mase cKO (42hâ€“tet) determined Bradford vesicular membranes.                                               shown Fig. 8C (lanes 1 2). total    soluble protein                    [35S]-methionine incorporation protein (excluding
endocytic pathway, protein disulphide isomerise 2 (PDI-2)          VSG) cell lines similar (Fig. 8C, lanes 1
(Rubotham et al., 2006), similarly examined            2). 42 h time point, TbnSMase cKO cells
aberrant processing. 55 kDa polypeptide, PDI-2             essentially viable based ability synthesize
subsequently heavily glycosylated 80 kDa glyco-            protein level comparable wild-type cells.
protein Golgi, ultimately colocalizes p67           clear proportion newly synthe- terminal endosomes. Western blot analysis wild-             sized ([35S]-methionine labelled) VSG exported cell
type TbnSMase cKO (42hâ€“tet) cells PDI-2               surface, e. radiolabelled sVSG, drastically reduced
gift Derek Nolan) revealed equal amounts               TbnSMase cKO (42hâ€“tet) cells, compared

Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1472 S.  Young T. K. Smith äŠ?




Fig. 8. Phenotypic analysis protein trafficking nSMase conditional knockout.  Wild-type TbnSMase cKO cells grown absence tetracycline 42 h pulse labelled [35S]-methionine 1 h (lanes 1 3 respectively) chased 2 h (lanes 2 4 respectively) prior IP anti-P67 described Experimental procedures. resulting IP [35S]-proteins separated 10  SDS-PAGE gel, prior Coomassie blue staining (Fig. S6) fluorography. various maturation sizes P67 highlighted.
B. Anti-trypanopain Western blot analysis wild-type (lane 1) TbnSMase cKO cells grown absence tetracycline 42 h (lane 2)
shows incomplete endosomal processing. maturation sizes trypanopain highlighted.
C. Wild-type (lanes 1 3) TbnSMase cKO cells grown absence tetracycline 42 h (lanes 2 4) labelled [35S]methionine 1 h. Total [35S]-protein (lanes 1 2) [35S]-sVSG (soluble VSG-obtained cell surface parasite) (lanes 3 4) prepared described Experimental procedures separated 10  SDS-PAGE gel, visualized Coomassie blue fluorography. black arrow (lane 1) refers protein longer synthesized TbnSMase cKO (-tet) cells (lane 2).
D. Wild-type (lanes 1 2) TbnSMase cKO cells grown absence tetracycline 42 h (lanes 3 4) labelled [3H]myristate 1 h absence (lanes 1 4) presence cycloheximide (60 mg ml-1) (lanes 2 3) described Experimental
procedures. Densitometry (ImageJ) [3H]myristate-mfVSG (membrane form VSG, processes intact GPI-anchor) signals normalized 100  wild-type cells absence cycloheximide. Lower panel shows VSG portion gel stained Coomassie blue loading control.




                                                                  Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                            Neutral sphingomyelinase Trypanosoma brucei 1473
 Coomassie stained sVSG (Fig. 8C, lanes 3              currently, rate SM synthesis continues unabated
4) VSG221 Western blot analysis (Fig. S9B),              resulting increased SM levels product DAG, conclude rate newly synthesized           utilized catabolized.
VSG getting cell surface drastically                  depletion PC mitochondrion comes
reduced TbnSMase cKO (42hâ€“tet) cells.                   cells starved choline
protein bands sVSG similar amounts            cholineâ€“phosphate local pool choline [35S]-methionine incorporation, showing protein            tied SM. absence nSMase ER
synthesis taking place. exception       means cholineâ€“phosphate liberated, ~80 kDa protein (Fig. 8C, lane 1, black arrow), corre-         utilized synthesize PC Kennedy
sponding protein band identified mass finger-          pathway. parasite auxotrophic choline, printing possibly HSP-70 PDI-2, interestingly,        source choline containing phospholipids involved protein folding.                     host environment, probably primarily components
    investigate defect VSG synthesis,           low-density-lipoprotein (LDL).  subsequent exocytosis, wild-type TbnSMase                 nSMase cKO grown permissive conditions, cKO (42hâ€“tet) cell lines labelled [3H]-myristate.        greatly reduced endocytic flux, ultimately prevent- expected wild-type cells mature membrane form            ing catabolism pre-exisiting endosomal SM
GPI-anchored VSG (mfVSG) [3H]-myristate labelled               PC,  freshly endocytosed extracellular SM
(Fig. 8D, lane 1). corresponding [3H]-myristate                PC.
labelled mfVSG TbnSMase cKO (42hâ€“tet) cells                    consequence shift choline usage significantly reduced (~12 ) (Fig. 8D, lane            mitochondrial associated SM synthase ultimately runs 4). significant reduction prompted assessment           normal substrate, PC, starts utilize PI instead, myristate exchange GPI anchor pre-existing           giving rise unusual IPC formation blood-
VSG, takes place endocytosis. previously           stream form T. brucei. pool PI ER derived
shown, presence cycloheximide  inhibit protein        novo synthesized inositol (Martin Smith,
synthesis), myristate exchange wild-type cells              2006b). implies mitochondrial SM synthase
shows residual ~30  (Fig. 8D, lane 2) [3H]-myristate             utilize PC PI substrates synthesis
incorporation (Buxbaum et al., 1996).               SM IPC respectively.  bloodstream
TbnSMase cKO (42hâ€“tet) cells incorporation                  form parasite prefers utilize PC, uses
reduced mere ~3  compared wild-type level.               PI PC available. contrast procyclic cells
Despite significantly reduced myristate             substantial amounts IPC observed exchanging happening TbnSMase cKO (42hâ€“tet) cells,              purified mitochondria, despite ample PC avail- approximately ratio myristate exchange        able (GÃ¼ler et al., 2008).
total myristylated mfVSG observed wild-type cells, e.            alternative possibility observed IPC formation
3â€“12  30â€“100  respectively. indicates                novo synthesized ceramide translocated
despite rate endocytoses exocytoses mfVSG            Golgi resident SM synthase (SLS4), significantly reduced ratio (relationship)          known capable utilizing PC PI (Mina
maintained.                                                        et al., 2009), starved PC utilizes different pool                                                                    PI, synthesized Golgi extracellular
                                                                   inositol (Martin Smith, 2006a). transition PC Discussion                                                         PI utilization substrates mitochondrial SM syn- essentiality TbnSMase clearly shows            thase(s) occurs bloodstream long-slender novo synthesis ceramide compensate            stumpy form differentiation, IPC formation clearly
loss ceramide formation SM catabolism ER.            observed dramatic upregulation mitochon-
   nSMase cKO trypanosomes grown permis-                 drial associated SM synthase (SLS1) (Kabani et al.,
sive conditions shows significant increase intra-        2009). observations imply stumpy celluar SM levels, ER mitochondria        procyclic form parasites significantly decreased SM synthase present. conjunction            rate ceramide formation ER, little, excess SM significant decrease PC, corre-             SM nSMase catabolize, flux sponding increase intracelluar DAG. observed                post-Golgi sorting protein destined recycling
increase DAG species diacyl chain length            endosomes flagellar pocket, dependent depleted PC species (C38:5 C40:5) implies               ceramide ER, severely reduced. novo synthesis PC Kennedy pathway              Collectively, results allow propose slowed, synthesis DAG                   updated model endocytic exocytic pathways resulting excess DAG. Alternatively, likely         bloodstream form T. brucei (Fig. 9A), expla-

Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1474 S.  Young T. K. Smith äŠ?




Fig. 9. Schematic pathways involved endocytosis exocytosis bloodstream form T. brucei: wild-type   nSMase cKO
grown permissive conditions (B). difference width arrows   (B) depicts relative changes flux vesicular trafficking pathway wild-type cells compared nSMase cKO grown permissive conditions. Dashed arrows
indicate putative pathways. enlarged flagellar pocket late endosomes representative â€˜Big-Eyeâ€™ phenotype observed nSMase cKO grown permissive conditions (B). Annotated cellular structures: EE, early endosomes; ER, endoplasmic reticulum; FP,
flagellar pocket; G, Golgi; L, lysosome; LE, late endosomes; M, mitochondria; MAM, mitochondrion associated membrane; PM, plasma
membrane;  recycling endosomes; FL, flagellum. various types vesicles numbered follows: 1. Endocytic clathrin-coated
vesicles flagellar pocket early endosomes, carrying mixture endocytosed nutrients, including LDL particles transferrin bound GPI-anchored transferrin receptor, recycling pre-existing cell surface GPI-anchored VSG, checked undergoing myristate
exchange. 2. Clathrin-coated vesicles early endosomes recycling endosomes carrying recycling pre-existing cell surface GPI-anchored
VSG. 3. Clathrin-coated vesicles early endosomes late endosomes, carrying mixture endocytosed nutrients, including LDL
particles transferrin bound GPI-anchored transferrin receptor. 4. Clathrin-coated vesicles late endosomes recycling endosomes,
carrying recycled GPI-anchored transferrin receptor, free transferrin, newly synthesized membrane-bound protein destined flagellar pocket, newly synthesized GPI-anchored proteins, e. VSG. 5. Non-clathrin-coated, sphingomylein-enriched recycling
endosomes destined flagellar pocket, contains recycling GPI-anchored transferrin receptor, recycling VSG newly synthesized
VSG. 6. Non-clathrin-coated, SM-enriched vesicles trans-Golgi cisterna recycling endosomes, containing newly synthesized
VSG possibly GPI-anchored proteins, ultimately destined flagellar pocket cell surface. 7. Clathrin-coated vesicles Golgi late endosomes, containing newly synthesized proteins targeted lysosome, e. p67 trypanopain, recycling endosomes flagellar pocket, e. cell surface proteins VSG. 8. Clathrin-coated vesicles late endosomes lysosome, containing mixture newly synthesized lysosomal proteins, e. p67 trypanopain, endocytosed nutrients, e. LDL particles transferrin. 9. CopII vesicles ER Golgi, carrying newly synthesized proteins
destined endocytic pathway. 10. Putative non-CopII vesicles going ER Golgi, possibly carrying lipids, e.g.
ceramide PC. 11. Putative SM-enriched vesicle trafficking VSG directly Golgi flagellar pocket.




                                                                  Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                          Neutral sphingomyelinase Trypanosoma brucei 1475

nation effect pathways caused                   subset Cop II vesicles selectively transporting GPI- nSMase cKO grown permissive conditions                   anchored cargo, e.g. VSG, ER Golgi (Sevova
(Fig. 9B).                                                         Bangs, 2009), vesicles contain    Let discuss model bloodstream form             ceramide PC SM synthesis. parasite. PC exclusively novo synthesized              model suggests post-Golgi sorting proteins
Kennedy pathway (Gibellini et al., 2009) ceramide              takes place trans-Golgi network clathrin- utilized mitochondrial resident SM synthase            coated vesicles late endosome (Fig. 9, route 7), form SM. SM translocated ER,           SM-enriched vesicles recycling endosomes (Fig. 9,
mitochondria-associated membrane fraction (Bionda                  route 6).
et al., 2004; Achleitner et al., 1999), SM                  Proteins p67 trypanopain targeted encounters nSMase, forming ceramide cholineâ€“               translocated lysosome (Fig. 9, route 8) unaf-
phosphate (Vacaru et al., 2009). ER pool cera-             fected lack SM formation Golgi mide travels PC ER Golgi             nSMase cKO cells grown permissive conditions.
(Fig. 9, route 9) (Testerink et al., 2009),           Note, processing sorting enlarged late endo-
trans-Golgi cisterna, different SM synthase, SLS4                proteins affected, e. trypanopain, (Tb09211.1000) (Sutterwala et al., 2008), utilizes           likely p67 processing trypanopain, normally
lipid precursors reform SM, subsequently               lysosomal, partially happens enlarged late
used post-Golgi processing GPI-anchored pro-                endosomes.
teins, e VSG. similar situation yeast,            late endosomes lysomal targeted proteins IPC, formed Golgi ceramide novo               joined endocytosed nutrients, e. transferrin LDL,
synthesies ER PI, influences GPI-anchored               previously sorted recycling VSG
protein trafficking (Watanabe et al., 2002). explains         early endosomes (reviewed Overath Eng- inhibition ceramide novo pathway                  stler, 2004) (Fig. 9, route 3), translocated lyso-
myrocin, lethal did affect transport GPI-          (Fig. 9, route 8).
anchored VSG (Sutterwala et al., 2007).                               cell surface proteins, e. invariant surface glyco-
   case nSMase cKO grown permissive            protein 65 recycling transferrin receptor, conditions, decreasing levels nSMase activity directly          sorted recycling endosomes (Fig. 9, route 4) join
cause lack ceramide ultimately lack PC               recycling VSG newly synthesized VSG (discussed eariler) ER, subsequently reduces          route flagellar pocket (Engstler et al., 2004). ceramide travelling Golgi (Fig. 9,               alternative post-Golgi sorting pathway utilizes
route 9). subsequent lack SM synthesis Golgi         SM-enriched vesicles carry newly synthesized VSG,
decreases rate (flux) SM-enriched vesicles            recycling endosomal network (Fig. 9, route
containing newly synthesized VSG translocated            6) putatively suggested, directly recycling endosomes (Fig. 9, route 6),           flagellar pocket (Fig. 9, route 11). flagellar pocket (Fig. 9, route 5). subsequently             recycling endosomes likely
decreases flux exiting late endosomes (Fig. 9,             place myristate exchange pre-existing newly
route 4), causing enlarge, reduces                 synthesized GPI-anchored VSG potentially endocytic rate pre-exisitng cell surface VSG (Fig. 9,           GPI-anchored proteins, e. transferrin receptor takes
route 1), early endosomes recycling endo-          place (Buxbaum et al., 1996).
somes (Fig. 9, route 2).                                              high flux SM-enriched recycling endosomes
   organisms general question arises,            delivers cargo flagellar pocket (Fig. 9, route 5),
SM translocated ER Golgi?               allowing SM recycled endocytosis (Fig. 9,
possible answer transportation SM              route 1), early late endosomes lyso- ER Golgi detrimental cis-Golgi            (Fig. 9, routes 3 8), catabolized
cisterna enzymes  e. glycosidases             putative acidic SMase (Tb 927.4.1120), glycosyltransferases. Alternatively, SM suitable        activity shown work SM PC containing Cop II vesicle formation (Fig. 9, route 9), used      LDL (Coppens et al., 1995). protein trafficking ER Golgi (Hughes                  Based model results, flux
Stephens, 2008). previously proposed possibility           endosomal pathway highly dependent lipids ceramide PC transported          high rates flux avenues Golgi CopII independent vesicles (Funato               post-Golgi sorting, e. late endosome recy-
Reizman, 2001) (Fig. 9, route 10), SM                cling endosomes. extrapolate model  translocated using vesicles unknown.            reduction flux post-Golgi
Interestingly, T. brucei recently shown use          sorting recycling endosomes, ultimately 
Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1476 S.  Young T. K. Smith äŠ?

flagellar pocket (exocytosis) (Fig. 9B, routes 6 5),       TbnSMase ORF excised using HindIII PacI, nSMase cKO VSG RNAi (Sheader et al.,                subsequently ligated tetracycline-inducible expres-
2005; Smith et al., 2009), flux late          sion vectors pLew82 pLew100 (Wirtz et al., 1999)                                                                   HindIII PacI restriction sites. Plasmid DNA prepared
endosome (Fig. 9B, routes 3 4) affected;                                                                   linearization NotI subsequently precipitated turn causing decrease rate protein trafficking        sodium acetate/ethanol redissolved sterile water exocytic pathway ultimately                   final concentration 2 mg ml-1, ready transfection.
endocytic pathway. lack protein trafficking recycling endosomes causes enlargement late
endosome.  new material entering flagellar           Construction T. brucei gene replacement cassettes
pocket processed leading enlargement              5â€² 3â€² untranslated regions (UTRs) immediately adja- flagellar pocket, characteristically known        cent nSMase ORF amplified T. brucei
â€˜Big-Eyeâ€™ phenotype.                                              genomic DNA using KOD Hot Start DNA polymerase.     high endocytic exocytic rates blood-            primers 5â€²-ATAAGTAAGCGGCCGCGCGTTTGGGCTGTT
stream form T. brucei dependent high flux             CTCGTT-3â€² 5â€²-CGTTTAAACTTACGGACCGTCAAGCTT
                                                                  TTTTGAGTTTAATTCAGTGGG-3â€² used 5â€² UTR,
SM-enriched vesicles Golgi recycling
                                                                  amplifying expected 468 bp product, primers
endosomes flagellar pocket/cell                 5â€²-tgacggtccgtaagtttaaacggATCCAGAGGATTGCTTCATCAT
surface. explains difference significantly        CATG-3â€² 5â€²-ATAAGTAAGCGGCCGCTCCCCTCTGCG
higher endocytic exocytic fluxes mammalian             TAGTGGTAAAATA-3â€² resulted correct 298 bp product
bloodstream form parasite compared            3â€² UTR. amplified products used procyclic insect form parasites.                       subsequent knitting PCR, resulting 744 bp product    summary, T. brucei nSMase recombi-             5â€² UTR joined 3â€² UTR short
                                                                  complementary BamHI-HindIII linker region contained natly expressed shown catalytically active.                                                                   described primers (italics). PCR product ligated
high-throughput assay developed allowing future          pGEM-5Zf(+) (Promega) NotI sites (underlined high-throughput screening. Creation conditional              original primers) followed insertion hygro-
knockout bloodstream parasite allowed               mycin (HYG) puromycin (PAC) resistance genes genetic validation drug target, phenotype         cut BamHI HindIII restriction sites. Plasmid DNA given new insight highly active endocytic      prepared using QIAprep Miniprep Plasmid Kit (Qiagen), exocytic pathways bloodstream T. brucei.                   digested NotI precipitation sodium
                                                                  acetate/ethanol redissolved sterile water final
   work clearly demonstrates decrease                                                                   concentration 2 mg ml-1, ready transfection.
rate deposition newly synthesized VSG cell
surface causes corresponding decrease recycling VSG, allowing trypanosome maintain                   Cultivation genetic modification T. brucei
optimum cell density crucial VSG protective coat.
                                                                  Bloodstream form T. brucei strain 427, pre-  new possible strategy fight African        viously modified express T7 polymerase trypanosomasis drugs selectively interfere        tetracycline repressor protein (Wirtz et al., 1999), referred post-Golgi transport VSG. end          wild-type cells convenience. Cells grown
currently investigating nSMase inhibitors potential anti-      HMI-9 media supplemented G418 (2.5 mg ml-1), trypanosomal drugs.                                               37Â°C 5  CO2 described (Wirtz et al., 1999;
                                                                  Chang et al., 2002; Roper et al., 2002). Transformation 
                                                                  ditions subsequent drug selection described
                                                                  (Burkard et al., 2007). Addition tetracycline Experimental procedures                                           media required final concentration                                                                   1 mg ml-1. tetracycline-free experiments, Tet 
Cloning T. brucei nSMase gene ligation            approved fetal calf serum (Clontech) used cells pLew vectors                                                      washed times tetracycline-free HMI-9 resus-
                                                                  pended tetracycline-free media 5 Â¥ 104 putative nSMase gene identified T. brucei
                                                                  cells ml-1. Cells counted day passaged
genome database (Tb927.5.3710 â€“ Sanger Institute).
                                                                  density greater 7 Â¥ 105 cells ml-1 ORF amplified T. brucei strain 427
                                                                  (normally second day).
genomic DNA using forward reverse primers
5â€²-GAGGAGAAGCTTATGGCTGCAGAGATAACTG-3â€² 5â€²-TGCTTAATTAATTTACAACCATTACCTTTATGC-3â€²                       Expression T. brucei nSMase E. coli
taining HindIII PacI restriction sites respectively
(underlined). band expected size c. 1.7 kb        nSMase ORF amplified TbnSMase-TOPO
amplified using KOD Hot Start DNA polymerase (Merck Bio-          plasmid KOD Hot Start DNA polymerase using sciences , purified using QIAquick PCR purification kit     primers 5â€²-GAGGGATCCATGGCTGCAGAGATAACTGTTC-
(Qiagen) cloned pCR-Blunt II TOPO (Invitrogen).          3â€² 5â€²-TGCCCCGGGTCATTTACAACCATTACCTTTATG-

                                                          Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                              Neutral sphingomyelinase Trypanosoma brucei 1477

3â€², resulting single band c. 1.7 kb. amplified product   10 mM MgCl2, 0.5  glycerol varying amounts SM purified using QIAquick PCR purification kit (Qiagen)          (presented mixed micelles 0.1  Triton-X 100). Pro-
prior blunt-end cloning pCR-Blunt II-TOPO (Invitrogen)       duction choline phosphate SM detected inclu- sequencing. reading frame digested               sion standard Amplex red assay components final
ligated pGEX-6P-1 vector (GE Healthcare) using          assay volume 200 ml. Reaction mixtures incubated BamHI SmaI sites (underlined) sequence               30Â°C 1 h fluorescence product generated mea-
firmed. construct transformed E. coli C43 (DE3)        sured kinetically (Excitation 56 0nm, Emission 587 nm). T.
competent cells expression. single colony used          brucei bloodstream form washed membranes prepared inoculate 5 ml Luriaâ€“Bertani media containing 100 mg ml-1         containing estimated 35 mg total protein
ampicillin 0.5  glucose (w/v) grown 37Â°C             assayed nSMase activity identical manner night. 5 ml added 500 ml overnight express             100 mM SM (presented mixed micelles 0.1  Triton-X
instant TB medium (Merck Biosciences  containing                 100). Inhibitor studies trypanosomal membranes
100 mg ml-1 ampicillin grown 37Â°C 4 h,        conducted pre-incubation 500 mM inhibitor culture incubated 20 h 25Â°C. Cells     15 min, prior addition 100 mM SM, Amplex
harvested centrifugation (1800 g, 15 min) resus-              red 30 min 37Â°C.
pended lysis buffer [50 mM Tris pH 8.0, 300 mM NaCl, 10              Inhibitor studies GSTâ€“TbnSMase conducted Glycerol (v/v), 5 mM MgCl2, 1 mM DTT] incubated 37Â°C          pre-incubation 50 mM inhibitors 30 min prior addi- 0.2 mg ml-1 lysozyme (Sigma) 250 U benzonase                tion 100 mM SM Amplex red 30 min 37Â°C.
nuclease (Merck) 30 min. Cells disrupted sonica-
tion (4 Â¥ 60 s) ice cell debris, cells ghosts cleared slow-speed centrifugation (14 500 g,          Southern blots
10 min, 4Â°C). Expression identification GSTâ€“
                                                                     nSMase ORF PCR-amplified using ORF
TbnSMase confirmed Western blotting using anti-GST
                                                                     primers pLew vectors gel purified labelled
antibodies (Covance) ECL Western detection reagents
                                                                     DIG- (Roche). Genomic T. brucei DNA (3 mg) (Amersham). Subsequently, E. coli membranes containing
                                                                     digested various restriction enzymes. Digestion products
GSTâ€“TbnSMase collected high-speed centrifugation
                                                                     separated 0.8  agarose gel transferred (100 000 g, 1 h), washed PBS suspended 100 mM
                                                                     Hybond-N+ membrane (Amersham), hybridized 
Tris (pH 7.4), 10 mM MgCl2 20  glycerol stored                                                                      night ULTRA-HYB (Ambion) 42Â°C dig-labelled
aliquots -80Â°C. Protein extracted GSTâ€“
                                                                     nSMase ORF probe. Stringency washes carried TbnSMase membranes solubilizing 1  Triton X-100 prior
                                                                     42Â°C, consisted washes low stringency determining total protein content using BCA protein
                                                                     15 min [2Â¥ SSC (300 mM NaCl, 30 mM sodium citrate),
assay kit (Thermo Scientific).
                                                                     0.1  SDS] washes high stringency                                                                      15 min [0.2Â¥ SSC (30 mM NaCl, 3 mM sodium citrate),
nSMase enzyme assays                                                 0.1  SDS]. Bound probe detected anti-Dig antibody
                                                                     following manufacturers instructions.
Sphingomyelinase activity confirmed use radio-
active [3H]-SM, washed membranes (containing 127 mg total protein determined using BCA assay kit (Thermo         RNA isolation cDNA synthesis
Scientific) encoding GSTâ€“TbnSMase incubated 100 mM
                                                                     Total RNA isolated bloodstream form T. brucei using
Bis-Tris propane (pH 7.5), differing concentrations MgCl2
                                                                     RNeasy mini kit (Qiagen). TbnSMase-specific cDNA
 stated individual figures), 0.5  glycerol 25 nCi
                                                                     generated amplified using specific forward
[choline-methyl-3H]SM (50 Ci mmol-1, ARC) 50 pmol cold
                                                                     5â€²-GAGGAGCATATGGCTGCAGAGATAACTGTTC-3â€²                        SM presented mixed micelles 0.1  Triton-X 100.
                                                                     reverse 5â€²-TGCGGATCCTCAAGCTTCACATAGAGACGCC
Reactions incubated 37Â°C 120 min. Hydrolysis                                                                      TC-3â€² primers using SuperScript III step RT-PCR kit
PC assayed identical manner 30 nCi
                                                                     Platinum Taq (Invitrogen). negative control exclude
[3H-choline-methyl]PC (60 Ci mmol-1, ARC) 50 pmol cold
                                                                     DNA contamination RNA sample, reverse transcriptase
PC presented mixed micelles 0.1  Triton-X 100.                                                                      omitted reaction replaced GoTaq poly-
analysis optimum pH activity, pH reaction
                                                                     merase (Promega). Inositol-3-phosphate synthase (TbINO1)
buffer altered accordingly. Reactions (50 ml)                                                                      cDNA amplified using forward reverse
stopped addition 800 ml chloroform:methanol (2:1
                                                                     primers 5â€²-AGCGGCAAGCTTCTATGCCAGCCGTCCGTA
v/v) followed 250 ml H2O. phase separation, aqueous
                                                                     CGAAAA-3â€² 5â€²-CGACCTCGAGGTCAACTTCCCACG organic phases dried resuspended                                                                      CCGCGAAGGAAAGGCAG-3â€² confirm equal RNA loading.
50  propan-1-ol 100  butan-1-ol examined TLC
                                                                     PCR products run 1  agarose gel.
using solvent systems methanol:0.6  NaCl:25  NH3
(100:100:10) chloroform:methanol:water (10:10:3 v/v)
respectively.                                                        Subcellular localization studies
   Neutral sphingomyelinase activity character-
ized using Amplex Red sphingomyelinase assay kit (Invit-         Tetracycline-induced mid-log T. brucei nSMase-HA Ti blood-
rogen  et al., 2002). Briefly, washed membranes               stream form cells harvested centrifugation (800 g,
(containing 254 mg total protein) encoding GSTâ€“                   10 min) used immunofluorescence differential
TbnSMase incubated 100 mM Tris-HCl (pH 7.4),                 centrifugation previously described (Martin Smith,

Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1478 S.  Young T. K. Smith äŠ?

2006b). blocked cells incubated rat HA        concentration lysis buffer (1  Nonidet P-40, 0.5 
(Roche) rabbit trypanopain antibody (James Bangs, Uni-          deoxycholate, 0.1  SDS). Monoclonal anti-p67 (mAb280)
versity Wisconsin-Madison) followed respective           antibody  gift James Bangs, University Wisconsin-
secondary; FITC conjugated rabbit anti-rat (DakoCytomation)          Madison), recognizes uncharacterized peptide TRITC conjugated Goat anti-rabbit immunoglobulins                epitope p67 lumenal domain, preadsorbed (Sigma). 4,6-diamidino-2-phenylindole (DAPI) staining            Protein G-Sepharose 4B Fast Flow resin (Sigma) prior used reveal localization nuclear kDNA.             incubation solubilized protein 1 h 4Â°C.   Differential centrifugation Western analysis               incubation, resin beads washed times lysis
HA-tagged protein detected using primary rat HA           buffer buffer. Following centrifugation (Roche), secondary HRP-conjugated rabbit rat                   resin time point suspended equal volume
(Jackson) antibodies ECL Western detection reagents              2Â¥ SDS-PAGE sample buffer prior denaturing 100Â°C (Amersham) used described previously (Martin             10 min, release complexes protein G
Smith, 2006a).                                                       sepharose. Proteins separated 10  SDS-PAGE gel
                                                                     visualized Coomassie blue staining. detect [35S]-
                                                                     labelled proteins destained gel soaked En3hance vivo T. brucei metabolic labelling                                (NEN) detected autoradiography described  metabolic labelling, mid-log trypanosomes centrifuged (800 g, 10 min), washed minimal essential             FACS analysis
media resuspended specific supplement            Cells stained propidium iodide described previ-
free media final concentration 1 Â¥ 107 cells ml-1. Cells     ously (Hammarton et al., 2003). Briefly, cells fixed labelled 2 h 37Â°C [9,10-3H] myristic acid           70  methanol, 30  PBS (1Â¥106 cells ml-1) incubated (47 Ci mmol-1, Perkin Elmer) complexed defatted-BSA               4Â°C overnight. Cells washed cold PBS, resuspended
(1 mol mol-1) shaking water bath. Cells collected       1 ml PBS containing 10 mg ml-1 propidium iodide centrifugation (800 g, 10 min), washed twice trypanosome          10 mg ml-1 RNase  incubated 37Â°C 45 min. FACS
dilution buffer (TDB) buffer processed lipid       performed using Becton Dickinson FACScan using
protein analysis. Lipids extracted using chloroform:            detector FL2 
methanol: water (10:10:3 v/v) 1 h, supernatant
                                                                        Duplicate data sets collected analysed using
removed pellet extracted chloroform:methanol
                                                                     WinMDI software (http://facs.scripps.edu) utilizing 10 000
(2:1 v/v) 1 h. pooled supernatants dried, prior                                                                      events collected sample. Cells desalting using butanol/water partioning. Lipids sepa-
                                                                     particular stage cell cycle (G0/G1, S, G2/M >G2/M)
rated silica 60 high-performance layer chromatography
                                                                     indicated percentage total. gates used (HPTLC) plates, chloroform : methanol : ammonia
                                                                     quantification different stages Sheader et al.
(13 M) : ammonium acetate (1 M) : water, (180 : 140 : 9 : 9 :
                                                                     (2005).
23 v/v) solvent. Radiolabelled lipids detected fluorography -70Â°C, spraying En3hance using
                                                                     Lipidomic analysis
Kodak XAR-5 film intensifying screen. Protein samples
(cell pellets) quenched 2Â¥ SDS-PAGE sample buffer            Phospholipid analysis performed bloodstream wild- heated 95Â°C 5 min. Proteins separated           type TbnSMase cKO trypanosomes (1 Â¥ 108) pres-
10  SDS-PAGE gel visualized Coomassie blue stain-             ence absence tetracycline 42 h. Cells harvested
ing. detect [3H]-labelled proteins destained gel          washed TDB extracted according method soaked En3hance (NEN) 30 min, washed water               Blighâ€“Dyer (Bligh Dyer, 1959), dried N2, times, soaked 10  glycerol dried exposed         stored 4Â°C analysed electrospray mass spec-
XAR-5 film -80Â°C.                                                 trometry (ES-MS ES-MS/MS) described previously
   labelling [35S]-methionine, mid-log cells          (Richmond Smith, 2007; Gibellini et al., 2009; Richmond
collected centrifugation, washed methionine free minimal       et al., 2010).
essential media resuspended media final
concentration 1 Â¥ 107cells ml-1. Cells labelled          Western blotting
1 h 20 mCi ml-1 [35S]-methionine (MP Biomedicals,
1175 Ci mmol-1) 37Â°C. Small-scale sVSG purification           Specific T. brucei proteins detected Western blot performed described previously (Jones et al., 2005).           analysis, using rabbit VSG221 rabbit
   immunoprecipitation (IP) [35S]-p67 T. brucei,     trypanopain (gifts James Bangs, University protocol Alexander et al. (2002) followed       Wisconsin-Madison) rabbit PDI-2  gift Derek
modifications. Briefly, 5 Â¥ 106 [35S]-methionine pulse-labelled      Nolan, Trinity College Dublin) antibodies secondary rat
(1 h) trypanosomes harvested time point (0          rabbit HRP-conjugated antibody (Jackson ImmunoRe-
2 h), washed PBS solubilized 500 ml lysis          search . ECL detection reagents (GE Healthcare) buffer  buffer, 1  Nonidet P-40, 0.5  deoxycholate,              utilized visualize signal.
0.1  SDS  buffer = 50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 5 mM EDTA)] containing protease inhibitor cocktail.          FITC-BSA uptake assay extracts precleared centrifugation (14 000 rpm,
5 min) detergents (1  Nonidet P-40, 0.5  deoxycho-            Mid-log trypanosomes harvested centrifugation
late, 0.1  SDS) added culture supernatants        (800 g, 10 min) resuspended 1 Â¥ 106 ml-1 minimal

                                                             Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                            Neutral sphingomyelinase Trypanosoma brucei 1479

essential media. cells preincubated 10 min             Simons, K. (2000) Lipid rafts function biosynthetic
37Â°C FITC-BSA added final concentration             delivery proteins cell surface yeast. Proc Natl
5 mg ml-1. incubation 30 min, cells har-           Acad Sci USA 97: 3254â€“3259.
vested centrifugation washed twice PBS remove         Bernardo, K., Krut, O., Wiegmann, K., Kreder, D., Micheli, M.,
unbound FITC-BSA, prior fixation 4  paraformaldehyde            SchÃ¤fer, R., et al. (2000) Purification characterization processed immunofluorescence analysis                      magnesium-dependent neutral sphingomyelinase described                                                       bovine brain. J Biol Chem 275: 7641â€“7647.
                                                                   Bertello, L., Goncalvez, M.F., Colli, W., Lederkremer,
Electron Microscopy                                                   R.M. (1995) Structural analysis inositol phospholipids
                                                                      Trypanosoma cruzi epimastigote forms. Biochem J transmission electron microscopy cell pellets fixed          310: 255â€“261. 24 h Peterâ€™s fixative (1.25  glutataldehyde, 1      Bionda, C., Portoukalian, J., Scmitt, D., Rodriguez-Lafrasse,
paraformaldehyde 0.08 M sodium cacodylate pH 7.2              C., Ardail, D. (2004) Subcellular compartmentalization
0.02  calcium chloride). Samples rinsed twice 1               ceramide metabolism: MAM (mitochondria-associated-
tannic acid 10 min post-fixed/stained 0.5  osmium            membrane) mitochondria? Biochem J 382: 527â€“
tetraoxide (aq) 1 h. Specimens rinsed twice          533.
distilled water fixation/staining 1  uranyl acid fol-    Bligh, E.G., Dyer, W.J. (1959) rapid method total lipid
lowed infiltration/embedding Spurr resin. Sections         extraction purification. J Biochem Physiol 37:
cut using Leica Ultracut UCT microtome, mounted piolo-           911â€“917.
form coated copper grids, post-stained 3  uranyl acid         Brickman, M.J., Balber, E. (1994) Transport lyso-
(aq) Reynoldâ€™s lead citrate examined using Tecnai           somal membrane glycoprotein Golgi endo-
12 BioTWIN FEI, operated 120 kV.                somes lysosomes cell surface African
Images collected using SIS Megaview III, 2 Â¥ 2             trypanosomes. J Cell Sci 107: 3191â€“3200.
montages.                                                          Burkard, G., Fragoso, C.M., Roditi,  (2007) Highly effi-
                                                                      cient stable transformation bloodstream forms Trypa-
Acknowledgements                                                      nosoma brucei. Mol Biochem Parasitol 153: 220â€“223.
                                                                   Buxbaum, L.U., Milne, K.G., Werbovetz, K , Englund, work supported TKSâ€™s Wellcome Trust               P.T. (1996) Myristate exchange Trypanosoma brucei
Senior Research Fellowship 067441, Wellcome project             variant surface glycoprotein. Proc Natl Acad Sci USA 93:
grant 086658. wish thank Jay Bangs, University               1178â€“1183.
Wisconsin generous gifts monoclonal p67 (mAb280)          Caffrey, C.R., Hansell, E., Lucas, K.D., Brinen, L.S., Hernan- trypanopain antibodies Derek Nolan, University           dez, , Cheng, J., et al. (2001) Active site mapping,
Dublin PDI-2 antibody. wish acknowledge              biochemical properties subcellular localization access mass spectrometry facilities St Andrews Uni-          rhodesain, major cysteine protease Trypanosoma
versity University Dundee. wish thank           brucei rhodesiense. Mol Biochem Parasitol 118: 61â€“73.
Meg Stark (York) doing EM.                                 Chang, T., Milne, K.G., Guther, M.L.G., Smith, T.K.,                                                                       Ferguson, M J. (2002) Cloning Trypanosoma
References                                                            brucei Leishmania major genes encoding                                                                       GlcNAc-phosphatidylinositol          N-acetylase        Achleitner, G., Gaigg, B., Krasser, , Kainersdorfer, E., Kohl-      glycosylphosphatidyl-inositol biosynthesis essential
   wein, S.D., Perktold, , et al. (1999) Association        African sleeping sickness parasite. J Biol Chem 277:
   endoplasmic reticulum mitochondria yeast facili-        50176â€“50182.
   tates interorganelle transport phospholipids         Chatterjee, S., Mayor, S. (2001) GPI-anchor    membrane contact. Eur J Biochem 264: 545â€“553.                      protein sorting. Cell Mol Life Sci 58: 1969â€“1987.
Alexander, D.L., Schwartz, K.J., Balber, E., Bangs,          Coppens, , Levade, T., Courtoy, P.J. (1995) Host
   J.D. (2002) Developmentally regulated trafficking           plasma low density lipoprotein particles essential
   lysosomal membrane protein p67 Trypanosoma brucei.              source lipids bloodstream forms Trypanosoma
   J Cell Sci 115: 3255â€“3263.                                         brucei. J Biol Chem 270: 5736â€“5741.
Ali, B.R.S., Pal, , Croft, S.L., Taylor, R.T., Field, M.C.   Cowart, L , Okamoto, Y., Lu, X., Hannun, Y  (2006)
   (1999) farnesyltransferase inhibitor manumycin          Distinct roles novo versus hydrolytic pathways    novel trypanocide complex mode action including          sphingolipid biosynthesis Saccharomyces cerevisiae.
   major effects mitochondria. Mol Biochem Para 104:               Biochem J 393: 733â€“740.
  67â€“80.                                                           Denny, P.W., Smith, D.F. (2004) Rafts sphingolipid
Allen, C.L., Goulding, D., Field, M.C. (2003) Clathrin-           biosynthesis kinetoplastid parasitic protozoa. Mol
  mediated endocytosis essential Trypanosoma brucei.            Microbiol 53: 725â€“733.
  EMBO J 22: 4991â€“5002.                                            Denny, P.W., Field, M.C., Smith, D.F. (2001) GPI-
Arenz, C., Thutewohl, M., Block, O., Waldmann, H.,                    anchored proteins glycoconjugates segregate lipid
  Altenbach, H.J., Giannis,  (2001) Manumycin                 rafts Kinetoplastida. FEBS Lett 491: 148â€“153.
  analogues irreversible inhibitors neutral         Denny, P.W., Shams-Eldin, H., Price, H.P., Smith, D.F.,   sphingomyelinase. Chem Biochem 2: 141â€“143.                          Schwarz, R.T. (2006) protozoan inositol phosphorylce-
Bagnat, M., KerÃ¤nen, S., Shevchenko, , Shevchenko, ,              ramide synthase: novel drug target defines new

Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
 1480 S.  Young T. K. Smith äŠ?

  class sphingolipid synthase. J Biol Chem 281: 28200â€“            Hofmann, K., Tomiuk, S., Wolff, G., Stoffel, W. (2000)
  28209.                                                               Cloning characterization mammalian brain-
Dickson, R.C., Sumanasekera, C., Lester, R.L. (2006)               specific Mg2+-dependent neutral sphingomyelinase. Proc
  Functions metabolism sphingolipids Saccharomy-             Natl Acad Sci USA 37: 5895â€“5900.
  ces cerevisiae. Prog Lipid Res 45: 447â€“465.                        Hughes, H., Stephens, D.J. (2008) Assembly, organiza-
Engstler, M., Thilo, L., Weise, F., GrÃ¼nfelder, C.G., Schwarz,         tion, function COPII coat. Histochem Cell Biol
  H., Boshart, M., Overath, P. (2004) Kinetics endocy-          129: 129â€“151.
  tosis recycling GPI-anchored variant surface            Huwiler, , Kolter, T., Pfeilschifter, J., Sandhoff, K.
  glycoprotein Trypanosoma brucei. J Cell Sci 117: 1105â€“            (2000) Physiology pathphysiology sphingolipid
  1115.                                                                metabolism signaling. Biochimica Biophysica Acta
Fridberg, , Olsen, C.L., Nakayasu, E.S., Tyler, K.M.,                1485: 63â€“99.
  Almeida, C., Engman, D.M. (2008) Sphingolipid syn-           Jones, D.C., Mehlert, M., GÃ¼ther, M.L., Ferguson,
  thesis necessary kinetoplast segregation cytoki-          M J. (2005) Deletion glucosidase II gene Trypa-
  nesis Trypanosoma brucei. J Cell Sci 121: 522â€“535.                nosoma brucei reveals novel N-glycosylation mechanisms
Funato, K., Reizman, H. (2001) Vesicular nonvesicu-            biosynthesis variant surface glycoprotein. J Biol
  lar transport ceramide ER Golgi apparatus              Chem 280: 35929â€“35942.
  yeast. J Cell Biol 155: 949â€“959.                                   Kabani, S., Fenn, K., Ross, , Ivens, , Smith, T.K., Ghazal,
Futerman, H., Riezman, H. (2005) ins outs             P., Matthews, K. (2009) Genome-wide expression pro-
  sphingolipid synthesis. Trends Cell Biol 15: 312â€“318.                filing vivo-derived bloodstream parasite stages Gibellini, F., Hunter, W.N., Smith, T.K. (2009) etha-          dynamic analysis mRNA alterations synchronous
  nolamine branch Kennedy pathway essential               differentiation Trypanosoma brucei. BMC Genomics 10:
  bloodstream form Trypanosoma brucei. Mol Micro-               427.
  biol 73: 826â€“843.                                                  Kaneshiro, E.S., Jayasimhulu, K., Lester, R.L. (1986)
Goni, F.M., Alonso,  (2002) Sphingomyelinases:                   Characterization inositol lipids Leishmania
  enzymology membrane activity. FEBS letters 531:                  donovani promastigotes: identification inostiol
  38â€“46.                                                               sphingophospholipid. J Lipid Res 27: 1294â€“1303.
Gonzalez-Zorn, B., Dominguez-Bernal, G., Suarez, M., Ripio,          Kitagaki, H., Cowart, L , Matmati, N., Montefusco, D.,
  M.T., Vega, Y., Novella, S., Vazquez-Boland, J                 Vaena Avalos, S., Novgorodov, S , et al. (2007) Isc1
  (1999) smcL gene Listeria ivanovii encodes sph-             regulates sphingolipid metabolism yeast mitochondria.
  ingomyelinase C mediates bacterial escape              Biocimica Biophysica Acta 1768: 2849â€“2861.
  phagocytic vacuole. Mol Microbiol 33: 510â€“523.                     Kitagaki, H., Cowart, L , Matmati, N., Montefusco, D.,
GÃ¼ler, J.L., KriegovÃ¡, E., Smith, T.K., Luke, J., Englund,         Gandy, J., Vaena Avalos, S., et al. (2009) ISC1-
  P.T. (2008) Mitochondrial fatty acid synthesis required       dependent metabolic adaptation reveals indispensable
  normal mitochondrial morphology function Trypano-             role mitochondria induction nuclear genes   soma brucei. Mol Microbiol 67: 1125â€“1142.                            diauxic shift Saccharomyces cerevisiae. J Biol Chem
GÃ¼ther, M.L.S., Lee, S., Tetley, L., Acosta-Serrano, ,           284: 10818â€“10830.
  Ferguson, M J. (2006) GPI anchored proteins free             Koynova, R., Caffery, M.C. (1995) Phases phase
  GPI glycolipids procyclic form Trypanosoma brucei             transitions sphingolipids. Biochim Biophys Acta
  non-essential growth, required colonization           1255: 213â€“236.
  tsetse fly components              Lahiri, S., Futerman, H. (2007) metabolism   surface coat. Mol Biol Cell 17: 5265â€“5274.                           function sphingolipids glycosphingolipids. Cell Mol
Hammarton, T.C., Clark, J., Douglas, F., Boshart, M.,              Life Sci 64: 2270â€“2284.
  Mottram, J.C. (2003) Stage-specific differences cell            Levine, T.P., Wiggins, C , Munro, S. (2000) Inositol
  cycle control Trypanosoma brucei revealed RNA                  phosphorylceramide synthase located Golgi appa-
  interference mitotic cyclin. J Biol Chem 278: 22877â€“            ratus Saccharomyces cerevisiae. Mol Biol Cell 11: 2267â€“
  22886.                                                               2281.
Hanada, K., Mitamura, T., Fukasawa, M., Magistrado, P ,            Luberto, C., Hassler, D.F., Signorelli, P., Okamoto, Y.,
  Horii, T., Nishijima, M. (2000) Neutral sphingolmyeli-           Sawai, H., Boros, E., et al. (2002) Inhibition tumor
  nase activity dependent Mg2+ anionic phospholip-              necrosis factor-induced cell death MCF7 novel
  ids intrraerythrocytic malaria parasite Plasmodium            inhibitor neutral sphingomyelinase. J Biol Chem 277:
  falciparum. Biochem J 346: 671â€“677.                                  41128â€“41139.
Hanada, K., Palacpac, N.M.Q., Magistrado, P , Kurokawa,            Martin, K.L., Smith, T.K. (2006a) glycosylphosphati-
  K., Rai, G., Sakata, D., et al. (2002) Plasmodium falci-             dylinositol (GPI) biosynthetic pathway bloodstream-form
  parum phospholipase C hydrolyzing sphingomyelin                  Trypanosoma brucei dependent novo synthe-
  lysocholinephospholipids possible target malaria            sis inositol. Mol Microbiol 61: 89â€“105.
  chemotherapy. J Exp Med 195: 23â€“34.                                Martin, K.L., Smith, T.K. (2006b) Phosphatidylinositol  X., Chen, F., McGovern, M.M., Schuchman, E.H.                  synthesis essential bloodstream form Trypanosoma
  (2002) fluorescence-based, high-throughput sphingomy-              brucei. Biochem J 396: 287â€“295.
  elin assay analysis Niemann-Pick disease            Matthews, K.R. (2005) developmental cell biology   disorders sphingomyelin metabolism. Anal                    Trypanosoma brucei. J Cell Sci 118: 283â€“290.
  Biochem 306: 115â€“123.                                              van Meer, G., Voelker, D.R., Feigenson, G.W. (2008)

                                                             Â© 2010 Blackwell Publishing  Molecular Microbiology, 76, 1461â€“1482
                                                                                           Neutral sphingomyelinase Trypanosoma brucei 1481

  Membrane lipids: behave.             Sheader, K., Vaughan, S., Minchin, J., Hughes, K., Gull, K.,
  Nat Rev 9: 112â€“124.                                                et al. (2005) Variant surface glycoprotein RNA interference
Mina, J.G., Pan, S.Y., Wansadhipathi, N.K., Bruce, C.R.,             triggers precytokinesis cell cycle arrest African
  Shams-Eldin, H., Schwarz, R.T., et al. (2009) Trypa-           trypanosomes. Proc Natl Acad Sci USA 102: 8716â€“8721.
  nosoma brucei sphingolipid synthase, essential enzyme         Smith, T.K., Vasileva, N., Gluenz, E., Terry, S., Portman, N.,
  drug target. Mol Biochem Parasitol 168: 16â€“23.                 Kramer, S., et al. (2009) Blocking variant surface glycopro-
Miroux, B., Walker, J.E. (1996) production pro-          tein synthesis Trypanosoma brucei triggers general
  teins Escherichia coli: mutant hosts allow synthesis       arrest translation initiation. PLoS 4: e7532.
  membrane proteins globular proteins high          Sutterlin, C., Doering, T., Schimmoller, F., Schroder, S.,   levels. J Mol Biol 260: 289â€“298.                                   Riezman, H. (1997) Specific requirements ER Mizutani, Y., Tamiya-Koizumi, K., Irie, F., Hirabayashi, Y.,         Golgi transport GPI-anchored proteins yeast. J Cell
  Miwa, M., Yoshida, S. (2000) Cloning expression            Sci 110: 2703â€“2714.
  rat neutral sphingomyelinase: enzymologica; character-        Sutterwala, S.S., Creswell, C.H., Sanyal, S., Menon, K.,
  ization identification essential histidine residues.        Bangs, J.D. (2007) novo sphingolipid synthesis
  Biochimica Biophysica Acta 1485: 236â€“246.                          essential viability, transport Muniz, M., Reizman, H. (2000) Intracellular transport         glycosylphosphatidylinositol-anchored proteins African
  GPI-anchored proteins. EMBO J 19: 10â€“15.                           trypanosomes. Euk